Suboxone Dosage Guide
Suboxone has a ceiling effect that methadone does not. Past about 24 mg of buprenorphine per day, you do not get more receptor occupancy. You get more side effects. That single fact shapes every dosing decision in the clinic, and it is the main reason most patients stabilize between 12 and 16 mg, not higher.
Quick reference
| Phase | Typical dose | Notes |
|---|---|---|
| First dose (induction) | 2-4 mg | Patient must be in clear withdrawal first |
| Day 1 total | 4-12 mg | Titrate up by 2-4 mg every 2 hours as needed |
| Day 2-3 target | 8-16 mg | Most patients land here |
| Maintenance | 8-24 mg/day | 16 mg is the most common stable dose |
| FDA labeled max | 24 mg/day | Higher doses do not increase opioid blockade meaningfully |
Why 16 mg is the most common dose
Buprenorphine binds the mu opioid receptor with high affinity but only partially activates it. Receptor occupancy at 16 mg sits around 80 to 90 percent, which is enough to block most cravings and prevent withdrawal in the average patient. Push the dose to 24 mg and you may get a few more percentage points of occupancy. Push it further and you mostly get more constipation and headaches.
This is the meaningful difference between buprenorphine and methadone. Methadone has no ceiling. Higher doses keep doing more work. Buprenorphine plateaus, which makes it safer in overdose but harder to use as a high tolerance rescue.
Induction is the danger zone
Buprenorphine has higher receptor affinity than full agonists like heroin, oxycodone, or fentanyl. If a patient still has a full agonist on the receptor when they take their first dose of Suboxone, the buprenorphine knocks the agonist off and replaces it. The patient feels a sudden, severe withdrawal called precipitated withdrawal. It is the most common reason patients refuse a second induction attempt.
Standard guidance says to wait until the patient is in moderate withdrawal before the first dose. The clinical scoring tool is the COWS scale. A score of 11 or higher is the typical induction threshold. For short acting opioids like pharmaceutical heroin or oxycodone, that usually means 12 to 24 hours since last use.
Fentanyl breaks the standard induction
Fentanyl deposits in fat tissue. It releases back into the blood for days after last use, even when the patient feels withdrawal at the surface. That is why standard COWS based induction often produces precipitated withdrawal in fentanyl users. The patient is in withdrawal at the receptor where it counts, but enough fentanyl is still circulating that buprenorphine displaces it.
Two protocols are gaining traction:
- Low dose induction (microdosing). Start at 0.5 to 1 mg and increase slowly over 5 to 7 days while the patient continues to use the full agonist. The buprenorphine accumulates without displacing fentanyl.
- High dose rapid induction. Wait until clear withdrawal, then dose 16 mg quickly. The reasoning is that a higher first dose more fully occupies the receptor and overrides any precipitated withdrawal that does occur.
Both are off label. Both are being used in clinical practice. If you are inducting after primarily using fentanyl, ask your prescriber which protocol they use and why.
Suboxone film versus tablet versus generic
Generic buprenorphine/naloxone tablets and Suboxone film have the same active ingredients. The film dissolves faster and tastes mildly sweeter. Tablets are cheaper and absorbed slightly more slowly. Most patients tolerate both. If insurance forces a switch, the dose stays the same.
Subutex (buprenorphine alone, no naloxone) is reserved for pregnancy and rare cases of naloxone reaction. The naloxone component in Suboxone is there to prevent injection abuse. It is barely absorbed when the medication is taken sublingually as directed.
When 24 mg is appropriate
The FDA label tops out at 24 mg per day. That ceiling exists because the receptor occupancy plateau means more dose does not equal more benefit. There are exceptions:
- Patients still feeling cravings or withdrawal at 16 mg with confirmed adherence
- Pregnant patients with increased metabolism
- Patients taking liver enzyme inducers like rifampin or phenytoin
Some prescribers go to 32 mg in specific cases, particularly fentanyl users with persistent cravings on 24 mg. This is off label. Insurance often denies coverage above 24 mg without a prior authorization.
Side effects that matter
Constipation is universal and gets worse with dose. Most patients need a daily osmotic laxative. Headaches are common in the first two weeks and usually fade. Sweating, especially night sweats, is reported by about a third of patients and can persist for months. Tooth decay has emerged as a class effect, possibly tied to dry mouth and the acidic film vehicle. The FDA added a warning in 2022. Daily rinsing after dosing helps.